BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21086902)

  • 1. Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis.
    Handa T; Nagai S; Ueda S; Chin K; Ito Y; Watanabe K; Tanizawa K; Tamaya M; Mishima M; Izumi T
    Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):27-35. PubMed ID: 21086902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of matrix metalloproteinases in patients with pulmonary hypertension: data from a prospective study.
    Marc A; Pop C; Sitar-Taut AV; Budisan L; Berindan-Neagoe I; Pop D
    BMC Cardiovasc Disord; 2021 Dec; 21(1):607. PubMed ID: 34930125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
    Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
    Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
    Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
    Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Smoking Index Combined with NT-proBNP for Patients with Pulmonary Hypertension Due to Chronic Lung Disease: A Retrospective Study.
    Sun L; Zhao X; Guo Y; Hou X; Li J; Ren X; Dong L; Liang R; Nie J; Shi Y; Qin X
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1233-1245. PubMed ID: 38854590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.
    Elstein D; Nir A; Klutstein M; Rudensky B; Zimran A
    Blood Cells Mol Dis; 2005; 34(3):201-5. PubMed ID: 15885602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?
    Allanore Y; Wahbi K; Borderie D; Weber S; Kahan A; Meune C
    Ann Rheum Dis; 2009 Dec; 68(12):1885-9. PubMed ID: 19054819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T; Giannakoulas G; Karvounis H; Sfetsios T; Koliakos G; Parcharidis G; Settas L
    Int J Cardiol; 2007 Sep; 121(1):135-7. PubMed ID: 17088004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants.
    Baptista MJ; Rocha G; Clemente F; Azevedo LF; Tibboel D; Leite-Moreira AF; Guimarães H; Areias JC; Correia-Pinto J
    Neonatology; 2008; 94(1):22-30. PubMed ID: 18160811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.
    Chi SY; Kim EY; Ban HJ; Oh IJ; Kwon YS; Kim KS; Kim YI; Kim YC; Lim SC
    Lung; 2012 Jun; 190(3):271-6. PubMed ID: 22246552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of NT-proBNP ratio (BNP-R) for early diagnosis of tachycardia-mediated cardiomyopathy: a pilot study.
    Nia AM; Gassanov N; Dahlem KM; Caglayan E; Hellmich M; Erdmann E; Er F
    Clin Res Cardiol; 2011 Oct; 100(10):887-96. PubMed ID: 21538234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Pro-Brain Natriuretic Peptide Serum Concentration in the Detection of Pulmonary Hypertension in Patients With End-Stage Lung Diseases Referred for Lung Transplantation.
    Nowak J; Hudzik B; Niedziela J; Rozentryt P; Zembala M; Gąsior M
    Transplant Proc; 2018 Sep; 50(7):2044-2047. PubMed ID: 30177106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.
    Blyth KG; Groenning BA; Mark PB; Martin TN; Foster JE; Steedman T; Morton JJ; Dargie HJ; Peacock AJ
    Eur Respir J; 2007 Apr; 29(4):737-44. PubMed ID: 17135228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.
    Allanore Y; Borderie D; Meune C; Cabanes L; Weber S; Ekindjian OG; Kahan A
    Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.